Coronavirus Screening Test Developed by Johns Hopkins Microbiologists
By HospiMedica International staff writers Posted on 20 Mar 2020 |
Image: Coronavirus screening test developed by Johns Hopkins microbiologists (Photo courtesy of John Hopkins University)
A team of clinical microbiologists from John Hopkins University (Baltimore, MD) have developed an in-house coronavirus screening test that could allow the health system to test about 1,000 people daily. The test would help people to quickly learn if they are infected with COVID-19 and also allow doctors to test people with whom such patients have come in contact.
The test, which analyzes a nasal or oral swab, was used for the first time on March 11 by the microbiologists who performed around 85 tests during the first three days. The team expects to quickly ramp up capacity and test 180 people per day next week and 500 people in the week after that to reach 1,000 tests per day by early April. Currently, the test delivers results in about 24 hours, which the doctors hope to shorten to three hours.
“We will be able to diagnose more cases. This will allow the control of exposure,” said Heba Mostafa, M.B.B.Ch., Ph.D., assistant professor of pathology and director of the molecular virology laboratory at The Johns Hopkins Hospital.
“Testing is very important in terms of identifying cases so epidemiologists can then contact people exposed to individuals who are known to be positive and make recommendations about home isolation and further follow-up,” added Karen Carroll, M.D., professor of pathology and director of the Division of Medical Microbiology at Johns Hopkins.
Related Links:
John Hopkins University
The test, which analyzes a nasal or oral swab, was used for the first time on March 11 by the microbiologists who performed around 85 tests during the first three days. The team expects to quickly ramp up capacity and test 180 people per day next week and 500 people in the week after that to reach 1,000 tests per day by early April. Currently, the test delivers results in about 24 hours, which the doctors hope to shorten to three hours.
“We will be able to diagnose more cases. This will allow the control of exposure,” said Heba Mostafa, M.B.B.Ch., Ph.D., assistant professor of pathology and director of the molecular virology laboratory at The Johns Hopkins Hospital.
“Testing is very important in terms of identifying cases so epidemiologists can then contact people exposed to individuals who are known to be positive and make recommendations about home isolation and further follow-up,” added Karen Carroll, M.D., professor of pathology and director of the Division of Medical Microbiology at Johns Hopkins.
Related Links:
John Hopkins University
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans